Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory T Chesnut

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Prostate Cancer and Prostatic Diseases|November 10, 2022
The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancerNatasza M Posielski, Santosh Shanmuga, On Ho, et al.
BJU International|October 30, 2020
Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumoursAditya Bagrodia, Anna Savelyeva, John T Lafin, et al.
Urology|August 24, 2021
Impact of Age and Race on Health-Related Quality of Life Outcomes in Patients Undergoing Radical Prostatectomy for Localized Prostate CancerNatasza Posielski, Jason Frankel, Huai-Ching Kuo, et al.
Urology|April 30, 2019
Contemporary Management of Hemorrhage After Minimally Invasive Radical ProstatectomyLucas W Dean, Amy L Tin, Gregory T Chesnut, et al.
Urology Practice|June 20, 2020
Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical ProstatectomyGregory T Chesnut, Nicole Benfante, David Barham, et al.
Urologic Oncology|February 15, 2021
Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancerGregory T Chesnut, Amy L Tin, Arjun Sivaraman, et al.
Cancer Medicine|May 31, 2022
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017Nathan Oehrlein, Samantha A Streicher, Huai-Ching Kuo, et al.
Cancer Medicine|May 26, 2022
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017Sean P Stroup, Audry H Robertson, Kayla C Onofaro, et al.
Journal of Pathology Informatics|July 2, 2024
A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancerSushant Patkar, Stephanie Harmon, Isabell Sesterhenn, et al.
European Urology Open Science|May 17, 2021
Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node DissectionJohn T Lafin, Alexander P Kenigsberg, Xiaosong Meng, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Prostate Cancer and Prostatic Diseases|November 10, 2022
The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancerNatasza M Posielski, Santosh Shanmuga, On Ho, et al.
BJU International|October 30, 2020
Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumoursAditya Bagrodia, Anna Savelyeva, John T Lafin, et al.
Urology|August 24, 2021
Impact of Age and Race on Health-Related Quality of Life Outcomes in Patients Undergoing Radical Prostatectomy for Localized Prostate CancerNatasza Posielski, Jason Frankel, Huai-Ching Kuo, et al.
Urology|April 30, 2019
Contemporary Management of Hemorrhage After Minimally Invasive Radical ProstatectomyLucas W Dean, Amy L Tin, Gregory T Chesnut, et al.
Urology Practice|June 20, 2020
Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical ProstatectomyGregory T Chesnut, Nicole Benfante, David Barham, et al.
Urologic Oncology|February 15, 2021
Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancerGregory T Chesnut, Amy L Tin, Arjun Sivaraman, et al.
Cancer Medicine|May 31, 2022
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017Nathan Oehrlein, Samantha A Streicher, Huai-Ching Kuo, et al.
Cancer Medicine|May 26, 2022
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017Sean P Stroup, Audry H Robertson, Kayla C Onofaro, et al.
Journal of Pathology Informatics|July 2, 2024
A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancerSushant Patkar, Stephanie Harmon, Isabell Sesterhenn, et al.
European Urology Open Science|May 17, 2021
Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node DissectionJohn T Lafin, Alexander P Kenigsberg, Xiaosong Meng, et al.
Pageof 5